Benzinga·Mar 4·Mohd HaiderActelis Networks Surges 55% on Major Caltrans Contract WinActelis Networks surges 55% after-hours on $120M Caltrans contract for MetaLight technology, expanding footprint in $90B smart transportation market. ASNSgovernment contractActelis Networks
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, Llc$ENPH Face Securities Fraud Class Action Over REC Credit Disclosure FailuresClass action lawsuit filed against Enphase Energy alleging securities fraud related to undisclosed channel inventory and tax credit impact concerns between April 2025 and October 2025. ENPHsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcuniQure Stock Crashes 49% After FDA Rejects Gene Therapy DatauniQure stock plunges 49% after FDA rejects gene therapy data for AMT-130, triggering securities fraud class action lawsuit for investors trading September-October 2025. QUREsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Globe NewswireBitget Wallet Launches Zero-Fee Crypto Card Across Latin AmericaBitget Wallet launches zero-fee crypto card in Latin America, enabling stablecoin spending with automatic USD conversion and 1.7% transaction savings. MALatin Americastablecoins
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcKyndryl Stock Plummets 55% Amid Internal Control Crisis, Class Action LoomsKyndryl Holdings faces securities fraud lawsuit over internal control failures and executive departures. Stock crashed 55% after delayed 10-Q filing disclosure. KDsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcUltragenyx Hit With Securities Lawsuit After Setrusumab Trial Failure Tanks Stock 42%Law firm Kahn Swick & Foti files class action against $UGXX over failed Phase 3 trial for rare bone disease drug setrusumab. Investors can apply as lead plaintiffs by April 6. KDNAVNRAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcClass Action Lawsuit Against Navan Seeks Lead Plaintiffs Before April 24 DeadlineKahn Swick & Foti, LLC filed class action lawsuits against Navan, Kyndryl, and Ultragenyx for alleged securities disclosure violations. Lead plaintiff applications due April 24, 2026. KDNAVNRAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcCoreWeave Faces Securities Fraud Class Action Over Demand, Supplier Risk ClaimsCoreWeave faces class action securities fraud lawsuit alleging overstatement of capacity and understatement of supplier risks between March-December 2025. Lead plaintiff applications due March 13, 2026. CRWVsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcCorcept Stock Crashes 50% After FDA Rejection; Securities Fraud Lawsuit FiledCorcept Therapeutics stock plummeted 50% after FDA rejected lead drug relacorilant. Investors allege prior misleading statements about approval likelihood. CORTsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcArdent Health Hit With Securities Fraud Suit Over Hidden Collections CrisisArdent Health faces securities fraud lawsuit over alleged failure to disclose collections problems. Stock fell 33% after November revelation of $43M revenue cut and $57.5M EBITDA guidance reduction. ARDTsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Kahn Swick & Foti, LlcBellRing Brands Hit With Securities Fraud Suit Over Hidden Inventory WoesBellRing Brands faces securities fraud lawsuit after 52% stock decline tied to undisclosed inventory issues and weak guidance, with investor deadline March 23, 2026. BRBRsecurities fraudclass action lawsuit
The Motley Fool·Mar 4·Daniel SparksAmazon Edges Tesla as AI Play on Valuation Gap and AWS MomentumTesla and Amazon shares fell in early 2026 amid market pullback. Amazon's AWS strength and 29x P/E valuation outweigh Tesla's AI ambitions versus 360x multiple. AMZNTSLAvaluationcloud computing
The Motley Fool·Mar 4·Eric TrieSCHO vs. ISTB: Treasury Purity or Yield Maximization in Short-Term Bond ETFsSCHO offers Treasury-only safety with 0.03% fees; ISTB provides 4.1% yield via 6,977 bonds but carries double fees and 63% deeper drawdowns. ISTBSCHOdividend yieldfixed income
GlobeNewswire Inc.·Mar 4·Bragar Eagel & Squire, P.C.Varonis Stock Plunges 49% After Revenue Miss; Class Action Deadline LoomsVaronis faces class action lawsuit over undisclosed business challenges. Stock crashed 48.7% after disappointing guidance. Investors must act by March 9, 2026. VRNSsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Bragar Eagel & Squire, P.C.Varonis Hit by Class Action Over ARR Misstatements as Stock Plunges 48.7%Varonis faces class action for allegedly misrepresenting ARR growth sustainability, triggering 48.7% stock collapse. Lead plaintiff deadline: March 9, 2026. VRNSsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·Bragar Eagel & Squire, P.C.Tennant Stock Plummets 23% After ERP Disaster Triggers Securities ProbeLaw firm investigates $TT after 23% stock crash following failed ERP system transition that cost $30M in sales and strained customer relationships. TNCshareholder lawsuitsecurities investigation
GlobeNewswire Inc.·Mar 4·Bragar Eagel & Squire, P.C.Shareholder Law Firm Probes Regencell, Camping World Over Securities ViolationsShareholder law firm investigates Regencell and Camping World for securities violations. Regencell faces DOJ trading probe; Camping World disclosed accounting restatements, Q4 losses, and suspended dividends. CWHRGCshareholder rightssecurities investigation
GlobeNewswire Inc.·Mar 4·Globe NewswireKDDI Delays Earnings Amid Internal Investigation, Drawing Securities LawsuitsKDDI delays earnings amid internal investigation, triggering 11.4% ADR decline and spurring Rosen Law Firm class action lawsuit. LUGSITKDDIYsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Mar 4·NaAura Minerals Secures Credit Rating Upgrade Amid Gold Rally and Production ExpansionAura Minerals upgraded to BB- globally and brAA+ in Brazil by S&P, reflecting strong gold prices and growing production targets through 2026. AUGOdividendEBITDA
The Motley Fool·Mar 4·Prosper Junior BakinyPharma Giant and Cloud Pioneer Lead Growth Stock Rally Into 2026Analysts spotlight $LLY's obesity drug dominance and $VEEV's cloud expansion as top growth picks for first half 2026. LLYVEEVlong-term investingGLP-1 drugs